You just read:

Senhwa Biosciences Reports Positive Phase 1 Data of CX-5461 in Patients With Advanced Solid Tumors at 2019 SABCS

News provided by

Senhwa Biosciences, Inc.

Dec 12, 2019, 15:00 ET